Physician profile
Hannah Jacques
NPI 1063301406
$1,652.61
in general payments reported to CMS, 2019-2025
11 companies · $1,653 in 2025
The $1,653 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $995 · Travel and Lodging: $612 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.38 |
| Travel and Lodging | $612.23 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,114.94 | 2025 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $208.55 | 2025 | General - Pain Management |
| Collegium Pharmaceutical, INC. | $83.90 | 2025 | Xtampza |
| Nalu Medical, INC. | $66.37 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $49.89 | 2025 | |
| Scilex Pharmaceuticals INC. | $38.16 | 2025 | |
| Tersera Therapeutics LLC | $24.98 | 2025 | Prialt |
| Curonix LLC | $17.58 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $16.99 | 2025 | Zilretta, Iovera |
| Pfizer INC. | $15.86 | 2025 | |
| Abbvie INC. | $15.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Jacques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.